The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Open accessAbstract
SUMMARY: Combination antibiotic therapy for invasive infections with Gram-negative bacteria is employed in many health care facilities, especially for certain subgroups of patients, including those with neutropenia, those with infections caused by Pseudomonas aeruginosa, those with ventilator-associated pneumonia, and the severely ill. An argument can be made for empiric combination therapy, as we are witnessing a rise in infections caused by multidrug-resistant Gram-negative organisms. The wisdom of continued combination therapy after an organism is isolated and antimicrobial susceptibility data are known, however, is more controversial. The available evidence suggests that the greatest benefit of combination antibiotic therapy stems from the increased likelihood of choosing an effective agent during empiric therapy, rather than exploitation of in vitro synergy or the prevention of resistance during definitive treatment. In this review, we summarize the available data comparing monotherapy versus combination antimicrobial therapy for the treatment of infections with Gram-negative bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632
Solomkin, J. S., Mazuski, J. E., Bradley, J. S., Rodvold, K. A., Goldstein, E. J. C., Baron, E. J., O'Neill, P. J., Chow, A. W., Dellinger, E. P., Eachempati, S. R., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649554 · Cited by 1,558
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Kumar, A., Ellis, P., Arabi, Y., Roberts, D., Light, B., Parrillo, J. E., Dodek, P., Wood, G., Kumar, A., Simon, D., et al. (2009) · Chest · doi:10.1378/chest.09-0087 · Cited by 1,187
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
Drenkard, E., & Ausubel, F. M. (2002) · Nature · doi:10.1038/416740a · Cited by 997
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Incidence, Risk, and Prognosis Factors of Nosocomial Pneumonia in Mechanically Ventilated Patients
Torres, A., Aznar, R., Gatell, J. M., Jiménez, P., González, J., Ferrer, A., Celis, R., & Rodriguez-Roisin, R. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.3.523 · Cited by 916
Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated Pneumonia
Luna, C. M., Vujacich, P., Niederman, M. S., Vay, C., Gherardi, C., Matera, J., & Jolly, E. C. (1997) · Chest · doi:10.1378/chest.111.3.676 · Cited by 916
(1999) · American Journal of Infection Control · doi:10.1016/s0196-6553(99)70031-3 · Cited by 901
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 889
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031
McDonald, L. C., Owings, M., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1203.051064 · Cited by 788
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
Bonomo, R. A., & Szabo, D. (2006) · Clinical Infectious Diseases · doi:10.1086/504477 · Cited by 741
Garnacho-Montero, J., Garcia-Garmendia, J. L., Barrero-Almodovar, A., Jimenez-Jimenez, F. J., Perez-Paredes, C., & Ortiz-Leyba, C. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000098031.24329.10 · Cited by 718
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq147 · Cited by 704
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.760-766.2005 · Cited by 692
Celis, R., Torres, A., Gatell, J. M., Almela, M., Rodríguez-Roisin, R., & Agustí-Vidal, A. (1988) · Chest · doi:10.1378/chest.93.2.318 · Cited by 683
Neuhauser, M. M., Weinstein, R. A., Rydman, R., Danziger, L. H., Karam, G., & Quinn, J. P. (2003) · JAMA · doi:10.1001/jama.289.7.885 · Cited by 678
Schimpff, S., Satterlee, W., Young, V. M., & Serpick, A. (1971) · New England Journal of Medicine · doi:10.1056/nejm197105132841904 · Cited by 673
Alvarez-Lerma, F., & ICU-Acquired Pneumonia Study Group (1996) · Intensive Care Medicine · doi:10.1007/bf01712153 · Cited by 652
Harbarth, S., Garbino, J., Pugin, J., Romand, J. A., Lew, D., & Pittet, D. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.07.005 · Cited by 637
Inadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized Patients
Kollef, M. H. (2000) · Clinical Infectious Diseases · doi:10.1086/314079 · Cited by 635
Schwaber, M. J., & Carmeli, Y. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm318 · Cited by 626
Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
Giske, C. G., Monnet, D. L., Cars, O., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01169-07 · Cited by 610
Resistance Mechanisms in Pseudomonas aeruginosa and Other Nonfermentative Gram‐Negative Bacteria
Hancock, R. E. W. (1998) · Clinical Infectious Diseases · doi:10.1086/514909 · Cited by 583
Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., & Quale, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1430 · Cited by 573
Kang, C., Kim, S., Kim, H., Park, S., Choe, Y., Oh, M., Kim, E., & Choe, K. (2003) · Clinical Infectious Diseases · doi:10.1086/377200 · Cited by 565
Hilf, M., Yu, V. L., Sharp, J., Zuravleff, J. J., Korvick, J. A., & Muder, R. R. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90695-5 · Cited by 563
Micek, S. T., Lloyd, A. E., Ritchie, D. J., Reichley, R. M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1306-1311.2005 · Cited by 526
The Influence of Mini-BAL Cultures on Patient Outcomes
MD, M. H. K., & Ward, S. (1998) · Chest · doi:10.1378/chest.113.2.412 · Cited by 494
Antibiotic Resistance in the Intensive Care Unit
Kollef, M. H., & Fraser, V. J. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-4-200102200-00014 · Cited by 478
Experience with a clinical guideline for the treatment of ventilator-associated pneumonia
Ibrahim, E. H., Ward, S., Sherman, G., Schaiff, R., Fraser, V. J., & Kollef, M. H. (2001) · Critical Care Medicine · doi:10.1097/00003246-200106000-00003 · Cited by 478
The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia
RELLO, J., GALLEGO, M., MARISCAL, D., SOÑORA, R., & VALLES, J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9607030 · Cited by 467
Paul, M., Benuri-Silbiger, I., Soares-Weiser, K., & Leibovici, L. (2004) · BMJ · doi:10.1136/bmj.38028.520995.63 · Cited by 466
Kumar, A., Zarychanski, R., Light, B., Parrillo, J., Maki, D., Simon, D., Laporta, D., Lapinsky, S., Ellis, P., Mirzanejad, Y., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181eb3ccd · Cited by 462
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 417
Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
Bush, K. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.006 · Cited by 398
Moskowitz, S. M., Foster, J. M., Emerson, J., & Burns, J. L. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.1915-1922.2004 · Cited by 397
Paul, M., Lador, A., Grozinsky-Glasberg, S., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub3 · Cited by 377
Health and Economic Outcomes of Antibiotic Resistance in Pseudomonas aeruginosa
Carmeli, Y., Troillet, N., Karchmer, A. W., & Samore, M. H. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1127 · Cited by 363
Bryan, C. S., Reynolds, K. L., & Brenner, E. R. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.4.629 · Cited by 360
The EORTC International Antimicrobial Therapy Cooperative Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198712313172703 · Cited by 345
Kumar, A., Safdar, N., Kethireddy, S., & Chateau, D. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e96b91 · Cited by 340
Montravers, P., Gauzit, R., Muller, C., Marmuse, J. P., Fichelle, A., & Desmonts, J. M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.486 · Cited by 329
Mortality Associated with Nosocomial Bacteremia Due to Methicillin-Resistant Staphylococcus aureus
Romero-Vivas, J., Rubio, M., Fernandez, C., & Picazo, J. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1417 · Cited by 318
Gales, A. C., Jones, R. N., Turnidge, J., Rennie, R., & Ramphal, R. (2001) · Clinical Infectious Diseases · doi:10.1086/320186 · Cited by 309
Initial Low‐Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic
Cosgrove, S. E., Vigliani, G. A., Campion, M., Fowler, Jr., Abrutyn, E., Corey, G. R., Levine, D. P., Rupp, M. E., Chambers, H. F., Karchmer, A. W., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597031 · Cited by 309
Self-citationSmith, A. L., Fiel, S. B., Mayer-Hamblett, N., Ramsey, B., & Burns, J. L. (2003) · Chest · doi:10.1378/chest.123.5.1495 · Cited by 307
Bratu, S., Tolaney, P., Karumudi, U., Quale, J., Mooty, M., Nichani, S., & Landman, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki175 · Cited by 307
Studies on antibiotic synergism against enterococci
Moellering, R. C., & Weinberg, A. N. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106758 · Cited by 302
Long-term Survival and Function After Suspected Gram-negative Sepsis
Perl, T. M. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530040066043 · Cited by 300
Falagas, M. E., Rafailidis, P. I., Ioannidou, E., Alexiou, V. G., Matthaiou, D. K., Karageorgopoulos, D. E., Kapaskelis, A., Nikita, D., & Michalopoulos, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.005 · Cited by 300
The clinical consequences of antimicrobial resistance
Rice, L. B. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.08.001 · Cited by 291
Obritsch, M. D., Fish, D. N., MacLaren, R., & Jung, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4606-4610.2004 · Cited by 288
Immunocompromised animal models for the study of antibiotic combinations.
Calandra, T., & Glauser, M. P. (1986) · PubMed · Cited by 287
Antibiotic Treatment for Surgical Peritonitis
MOSDELL, D. M., MORRIS, D. M., VOLTURA, A., PITCHER, D. E., TWIEST, M. W., MILNE, R. L., MISCALL, B. G., & FRY, D. E. (1991) · Annals of Surgery · doi:10.1097/00000658-199111000-00001 · Cited by 280
Leibovici, L., Paul, M., Poznanski, O., Drucker, M., Samra, Z., Konigsberger, H., & Pitlik, S. D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1127 · Cited by 280
Micek, S. T., Welch, E. C., Khan, J., Pervez, M., Doherty, J. A., Reichley, R. M., & Kollef, M. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01365-09 · Cited by 278
Garnacho-Montero, J., Sa-Borges, M., Sole-Violan, J., Barcenilla, F., Escoresca-Ortega, A., Ochoa, M., Cayuela, A., & Rello, J. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000275389.31974.22 · Cited by 275
Vidal, F. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440170139015 · Cited by 275
Paul, M., Soares-Weiser, K., & Leibovici, L. (2003) · BMJ · doi:10.1136/bmj.326.7399.1111 · Cited by 267
Linden, P. K., Kusne, S., Coley, K., Fontes, P., Kramer, D. J., & Paterson, D. (2003) · Clinical Infectious Diseases · doi:10.1086/379611 · Cited by 252
Gudiol, C., Tubau, F., Calatayud, L., Garcia-Vidal, C., Cisnal, M., Sanchez-Ortega, I., Duarte, R., Calvo, M., & Carratala, J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq494 · Cited by 246
Aaron, S. D., Ferris, W., Henry, D. A., Speert, D. P., & MacDonald, N. E. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9907147 · Cited by 240
Aaron, S. D., Vandemheen, K. L., Ferris, W., Fergusson, D., Tullis, E., Haase, D., Berthiaume, Y., Brown, N., Wilcox, P., Yozghatlian, V., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67060-2 · Cited by 240
Kett, D. H., Cano, E., Quartin, A. A., Mangino, J. E., Zervos, M. J., Peyrani, P., Cely, C. M., Ford, K. D., Scerpella, E. G., & Ramirez, J. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70314-5 · Cited by 235
Delay in appropriate therapy ofLegionella pneumonia associated with increased mortality
Heath, C. H., Grove, D. I., & Looke, D. F. M. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01695659 · Cited by 230
De Pauw, B. E., Deresinski, S. C., Feld, R., Lane-Allman, E. F., & Donnelly, J. P. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00004 · Cited by 228
Hancock, R. E., Raffle, V. J., & Nicas, T. I. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.5.777 · Cited by 219
Bliziotis, I. A., Samonis, G., Vardakas, K. Z., Chrysanthopoulou, S., & Falagas, M. E. (2005) · Clinical Infectious Diseases · doi:10.1086/430912 · Cited by 219
Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia
Chamot, E., Boffi El Amari, E., Rohner, P., & Van Delden, C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2756-2764.2003 · Cited by 218
Bench-to-bedside review: The role of β-lactamases in antibiotic-resistant Gram-negative infections
Bush, K. (2010) · Critical Care · doi:10.1186/cc8892 · Cited by 217
The Use of Systemic and Topical Fluoroquinolones
Bradley, J. S., Jackson, M. A., & the Committee on Infectious Diseases (2011) · Pediatrics · doi:10.1542/peds.2011-1496 · Cited by 216
Korvick, J. A., Bryan, C. S., Farber, B., Beam, T. R., Schenfeld, L., Muder, R. R., Weinbaum, D., Lumish, R., Gerding, D. N., & Wagener, M. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2639 · Cited by 212
Daikos, G. L., Petrikkos, P., Psichogiou, M., Kosmidis, C., Vryonis, E., Skoutelis, A., Georgousi, K., Tzouvelekis, L. S., Tassios, P. T., Bamia, C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00782-08 · Cited by 210
Microbial Resistance to Newer Generation f3-lactam Antibiotics: Clinical and Laboratory Implications
Sanders, C. C., & Sanders, W. E. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.3.399 · Cited by 210
Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
Gasink, L. B., Fishman, N. O., Weiner, M. G., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.029 · Cited by 206
Garnacho-Montero, J., Ortiz-Leyba, C., Herrera-Melero, I., Aldabo-Pallas, T., Cayuela-Dominguez, A., Marquez-Vacaro, J. A., Carbajal-Guerrero, J., & Garcia-Garmendia, J. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm460 · Cited by 205
SOLOMKIN, J. S., DELLINGER, E. P., CHRISTOU, N. V., & BUSUTTIL, R. W. (1990) · Annals of Surgery · doi:10.1097/00000658-199011000-00004 · Cited by 205
Cometta, A., Baumgartner, J. D., Lew, D., Zimmerli, W., Pittet, D., Chopart, P., Schaad, U., Herter, C., Eggimann, P., & Huber, O. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1309 · Cited by 202
Rice, L. B. (2008) · Clinical Infectious Diseases · doi:10.1086/526535 · Cited by 200
Solomkin, J. S., Reinhart, H. H., Dellinger, E. P., Bohnen, J. M., Rotstein, O. D., Vogel, S. B., Simms, H. H., Hill, C. S., Bjornson, H. S., Haverstock, D. C., et al. (1996) · Annals of Surgery · doi:10.1097/00000658-199603000-00012 · Cited by 192
Antibiotic combinations: should they be tested?
Eliopoulos, G. M., & Eliopoulos, C. T. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.2.139 · Cited by 189
McCabe, W. R. (1973) · Disease-a-Month · doi:10.1016/s0011-5029(73)80016-1 · Cited by 188
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
Kwon, K. T., Oh, W. S., Song, J.-H., Chang, H.-H., Jung, S.-I., Kim, S.-W., Ryu, S. Y., Heo, S. T., Jung, D. S., Rhee, J.-Y., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl499 · Cited by 188
Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative Infections
Klastersky, J., Cappel, R., & Daneau, D. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.6.470 · Cited by 186
Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.
Rc, M., Wennersten, C. B., & Weinberg, A. N. (1971) · PubMed · Cited by 186
Tamma, P. D., & Cosgrove, S. E. (2011) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.11.011 · Cited by 183
Self-citationFish, D. N., Piscitelli, S. C., & Danziger, L. H. (1995) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04366.x · Cited by 178
Aminoglycoside-induced hearing loss in humans
Brummett, R. E., & Fox, K. E. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.6.797 · Cited by 178
Paul, M., Dickstein, Y., Schlesinger, A., Grozinsky-Glasberg, S., Soares-Weiser, K., & Leibovici, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003038.pub2 · Cited by 177
Paramythiotou, E., Lucet, J., Timsit, J., Vanjak, D., Paugam‐Burtz, C., Trouillet, J., Belloc, S., Kassis, N., Karabinis, A., & Andremont, A. (2004) · Clinical Infectious Diseases · doi:10.1086/381550 · Cited by 177
Inducible -Lactamases: Clinical and Epidemiologic Implications for Use of Newer Cephalosporins
Sanders, W. E., & Sanders, C. C. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.830 · Cited by 176
Development of resistance during antibiotic therapy
Milatovic, D., & Braveny, I. (1987) · European Journal of Clinical Microbiology · doi:10.1007/bf02017607 · Cited by 174
Antimicrobial Synergism in the Therapy of Gram-Negative Rod Bacteremia
Anderson, E. T., Young, L. S., & Hewitt, W. L. (1978) · Chemotherapy · doi:10.1159/000237759 · Cited by 173
Mouloudi, E. K., Protonotariou, E., Zagorianou, A., Iosifidis, Ε., Karapanagiotou, A., Giasnetsova, T., Tsioka, A., Roilides, E., Sofianou, D., & Gritsi-Gerogianni, N. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/657135 · Cited by 171
Epidemiology and Risk Factors for Clostridium difficile Infection in Children
Sandora, T. J., Fung, M., Flaherty, K., Helsing, L., Scanlon, P., Potter-Bynoe, G., Gidengil, C. A., & Lee, G. M. (2011) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31820bfb29 · Cited by 169
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
Falagas, M. E., Karageorgopoulos, D. E., & Nordmann, P. (2011) · Future Microbiology · doi:10.2217/fmb.11.49 · Cited by 167
Long-term Survival Following Bacteremia or Fungemia
Leibovici, L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530100047033 · Cited by 166
Saiman, L., Mehar, F., Niu, W. W., Neu, H. C., Shaw, K. J., Miller, G., & Prince, A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.532 · Cited by 164
Lautenbach, E., Weiner, M., Nachamkin, I., Bilker, W., Sheridan, A., & Fishman, N. (2006) · Infection Control & Hospital Epidemiology · doi:10.1086/507274 · Cited by 159
Synergistic Combinations of Antibiotics in Gram-Negative Bacillary Infections
Klastersky, J., & Zinner, S. H. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.2.294 · Cited by 158
Vidal, L., Gafter-Gvili, A., Borok, S., Fraser, A., Leibovici, L., & Paul, M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm193 · Cited by 158
Kollef, M. H. (2003) · Drugs · doi:10.2165/00003495-200363200-00001 · Cited by 152
Furno, P., Bucaneve, G., & Favero, A. D. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00241-4 · Cited by 150
Aaron, S. D., Ferris, W., Ramotar, K., Vandemheen, K. L., Chan, F., & Saginur, R. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4172-4179.2002 · Cited by 148
Bisbe, J., Gatell, J. M., Puig, J. J., Mallolas, J., Martínez, J. A., de Anta, M. T. J., & Soriano, E. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.3.629 · Cited by 147
Paul, M., Grozinsky‐Glasberg, S., Soares‐Weiser, K., & Leibovici, L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub2 · Cited by 145
Trends in antimicrobial drug development: Implications for the future
Sergio Mella, M. (2005) · Revista chilena de infectología · doi:10.4067/s0716-10182005000200011 · Cited by 144
Impact of Clinical Guidelines in the Management of Severe Hospital-Acquired Pneumonia
Hoo, G. W. S., Wen, Y., Nguyen, T. V., & Goetz, M. B. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2778 · Cited by 143
Beardsley, J. R., Williamson, J., Johnson, J. W., Ohl, C. A., Karchmer, T. B., & Bowton, D. L. (2006) · CHEST Journal · doi:10.1378/chest.130.3.787 · Cited by 141
Lautenbach, E., Synnestvedt, M. B., Weiner, M. G., Bilker, W. B., Vo, L., Schein, J. R., & Kim, M. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/649021 · Cited by 140
Barie, P. S. (1997) · Archives of Surgery · doi:10.1001/archsurg.1997.01430360040008 · Cited by 140
A Step Closer to Extreme Drug Resistance (XDR) in Gram-Negative Bacilli
Paterson, D. L., & Doi, Y. (2007) · Clinical Infectious Diseases · doi:10.1086/522287 · Cited by 139
Conway, S. P., Pond, M. N., Watson, A., Etherington, C., Robey, H. L., & Goldman, M. H. (1997) · Thorax · doi:10.1136/thx.52.11.987 · Cited by 136
Malik, I. A., Abbas, Z., Karim, M. O., & Malik, I. A. (1992) · The Lancet · doi:10.1016/0140-6736(92)90674-r · Cited by 135
Sieger, B., Berman, S., Geckler, R. W., & Farkas, S. A. (1997) · Critical Care Medicine · doi:10.1097/00003246-199710000-00015 · Cited by 127
Amari, E. B. E., Chamot, E., Auckenthaler, R., Pechère, J. C., & van Delden, C. (2001) · Clinical Infectious Diseases · doi:10.1086/324346 · Cited by 127
Role of megalin in renal handling of aminoglycosides
Nagai, J., Tanaka, H., Nakanishi, N., Murakami, T., & Takano, M. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.2.f337 · Cited by 126
Martínez, J. A., Cobos-Trigueros, N., Soriano, À., Almela, M., Ortega, M., Marco, F., Pitart, C., Sterzik, H., López, J. D. S., & Mensa, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00115-10 · Cited by 125
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever
Hidalgo, M. M., Hornedo, J., Lumbreras, C., Trigo, J. M., Colomer, R., Perea, S., G�mez, C., Ruiz‐Casado, A., García‐Carbonero, R., & Cort�s-Funes, H. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990101)85:1<213::aid-cncr29>3.0.co;2-d · Cited by 123
Dupont, H., Carbon, C., & Carlet, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2028-2033.2000 · Cited by 120
Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
Ma, S., & Kb, C. (1976) · PubMed · Cited by 119
Giamarellou, H. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90490-0 · Cited by 118
Aarts, M.-A. W., Hancock, J., Heyland, D. K., McLeod, R. S., & Marshall, J. C. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000297956.27474.9d · Cited by 118
Ebbing, L., Metlay, J. P., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2005) · Clinical Infectious Diseases · doi:10.1086/432940 · Cited by 118
Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A Metaanalysis
Sanders, J. W., Powe, N. R., & Moore, R. D. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.5.907 · Cited by 117
Penicillin-Aminoglycoside Synergy in Experimental Streptococcus viridans Endocarditis
Sande, M. A., & Irvin, R. (1974) · The Journal of Infectious Diseases · doi:10.1093/infdis/129.5.572 · Cited by 115
Gribble, M. J., CHOW, A. W. C., Naiman, S. C., et al. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.3.388 · Cited by 113
Lee, J., Patel, G., Huprikar, S. S., Calfee, D. P., & Jenkins, S. G. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02466-08 · Cited by 110
Hidalgo, M. M., Hornedo, J., Lumbreras, C., et al. (1999) · PubMed · Cited by 110
Selection of Aminoglycoside-Resistant Variants of Pseudomonas aeruginosa in an in Vivo Model
Gerber, A., Vastola, A. P., Brandel, J., et al. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/146.5.691 · Cited by 108
Saiman, L. M., Chen, Y., Gabriel, P. S., & Knirsch, C. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1105-1107.2002 · Cited by 108
Gabriel, P. S., Zhou, J. J., Tabibi, S., Chen, Y., Trauzzi, M., & Saiman, L. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.168-171.2004 · Cited by 100
Paterson, D. L. (2008) · Clinical Infectious Diseases · doi:10.1086/590062 · Cited by 99
Niederman, M. S. (2005) · Clinical Infectious Diseases · doi:10.1086/499405 · Cited by 98
The utility of aminoglycosides in an era of emerging drug resistance
Zembower, T., Noskin, G. A., Postelnick, M. J., Nguyen, C., & Peterson, L. R. (1998) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00033-8 · Cited by 97
Montravers, P., Veber, B., Auboyer, C., Dupont, H., Gauzit, R., Korinek, A. M., Mallédant, Y., Martin, C., Moine, P., & Pourriat, J. L. (2002) · Critical Care Medicine · doi:10.1097/00003246-200202000-00017 · Cited by 97
RUOFF, G. E. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90121-x · Cited by 95
Chen, Y., Hsueh, P., Badal, R. E., Hawser, S., Hoban, D. J., Bouchillon, S. K., Ni, Y., & Paterson, D. L. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.02.009 · Cited by 95
Pankuch, G. A., Lin, G., Seifert, H., & Appelbaum, P. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00689-07 · Cited by 95
Cohn, S. M., Lipsett, P. A., Buchman, T. G., Cheadle, W. G., Milsom, J. W., O'Marro, S. D., Yellin, A. E., Jungerwirth, S., Rochefort, E. V., Haverstock, D. C., et al. (2000) · Annals of Surgery · doi:10.1097/00000658-200008000-00016 · Cited by 95
Falagas, M. E., Barefoot, L., Griffith, J., Ruthazar, R., & Snydman, D. R. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01690508 · Cited by 92
Tamma, P. D., Putcha, N., Suh, Y. D., Arendonk, K. J. V., & Rinke, M. L. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-181 · Cited by 88
Self-citationAl‐Hasan, M. N., Wilson, J. W., Lahr, B. D., Thomsen, K. M., Eckel‐Passow, J. E., Vetter, E. A., Tleyjeh, I. M., & Baddour, L. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01231-08 · Cited by 85
Rubinstein, E., Lode, H. M., Grassi, C., & Antibiotic Study Group (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1217 · Cited by 85
Clinical implications of β-lactam–aminoglycoside synergism: systematic review of randomised trials
Marcus, R., Paul, M., Elphick, H., & Leibovici, L. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.029 · Cited by 84
Servais, H., Jossin, Y., Bambeke, F. V., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1213-1221.2006 · Cited by 82
Efficacy of Meropenem as Monotherapy in the Treatment of Ventilator-Associated Pneumonia
Lerma, F. Á., & On Behalf of The Serious Infection Study Group (2001) · Journal of Chemotherapy · doi:10.1179/joc.2001.13.1.70 · Cited by 72
Archer, G. L., & Fekety, F. R. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.3.327 · Cited by 72
Schentag, J. J., Wels, P. B., Reitberg, D. P., et al. (1983) · Annals of Surgery · doi:10.1097/00000658-198307000-00007 · Cited by 70
Reinhardt, A. K., Köhler, T., Wood, P., Rohner, P., Dumas, J.-L., Ricou, B., & van Delden, C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01278-06 · Cited by 67
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis
Elphick, H., & Jahnke, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002007.pub3 · Cited by 66
Empirical monotherapy with meropenem in serious bacterial infections
Mouton, Y., Beuscart, C., & the Meropenem Study Group (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.suppl_a.145 · Cited by 66
Pseudomonas aeruginosa bloodstream infections: how should we treat them?
van Delden, C. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.06.015 · Cited by 66
Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit
Maragakis, L. L. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e6cbc5 · Cited by 64
Self-citationCombination Antimicrobial Treatment Versus Monotherapy: The Contribution of Meta-analyses
Paul, M., & Leibovici, L. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.01.004 · Cited by 58
Bliziotis, I. A., Michalopoulos, A. S., Kasiakou, S. K., Samonis, G., Christodoulou, C., Chrysanthopoulou, S. A., & Falagas, M. E. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.9.1146 · Cited by 57
Ohlin, B. (1999) · The European Journal of Surgery · doi:10.1080/11024159950189393 · Cited by 56
Hawser, S., Bouchillon, S. K., Lascols, C., Hackel, M., Hoban, D. J., Badal, R. E., & Cantón, R. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03550.x · Cited by 53
Johnson, P. R. E., Yin, J., & Tooth, J. A. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.2.203 · Cited by 51
Solomkin, J. S., Zhao, Y.-P., Ma, E., Chen, M., & Hampel, B. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.06.022 · Cited by 49
EMPIRIC MONOTHERAPY VERSUS COMBINATION THERAPY OF NOSOCOMIAL PNEUMONIA IN TRAUMA PATIENTS
Croce, M. A., Fabian, T. C., Stewart, R. M., Pritchard, F. E., Minard, G., Trenthem, L. L., & Kudsk, K. A. (1993) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199308000-00022 · Cited by 47
Lister, P., & Wolter, D. J. (2005) · Clinical Infectious Diseases · doi:10.1086/426190 · Cited by 47
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis
Elphick, H., & Tan, A. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002007.pub2 · Cited by 47
Paul, M., Schlesinger, A., Grozinsky‐Glasberg, S., et al. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003038 · Cited by 47
Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents
Gradelski, E., Kolek, B., BONNER, D. P., Valera, L., Minassian, B., & Fung-Tomc, J. C. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00317-4 · Cited by 44
Darras-Joly, C., Bedos, J. P., Sauve, C., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2147 · Cited by 44
Hoepelman, I. M., Rozenberg-Arska, M., & Verhoef, J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92121-6 · Cited by 42
Single Versus Combined Antibiotic Therapy for Gram-Negative Infections
Klibanov, O. M., Raasch, R. H., & Rublein, J. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d132 · Cited by 42
Chang, Y.-C., Huang, C., Wang, S.-T., & Chio, C. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00078-7 · Cited by 42
MONOTHERAPY VERSUS COMBINATION THERAPY FOR BACTERIAL INFECTIONS
Bouza, E., & Muñóz, P. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70293-5 · Cited by 40
Wu, Y. L., Scott, E. M., Po, A. L. W., & Tariq, V. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.3.389 · Cited by 39
Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa
Giamarellou, H., & Petrikkos, G. L. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.6.959 · Cited by 38
Imipenem versus tobramycin--antianaerobe antibiotic therapy in intra-abdominal infections.
Poenaru, D., Santis, M. D., & Nv, C. (1990) · PubMed · Cited by 38
Identifying Confounding by Indication through Blinded Prospective Review
Johnston, S. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.3.276 · Cited by 37
Mehtar, S. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.5.631 · Cited by 33
Barie, P. S., Hydo, L. J., Shou, J., & Eachempati, S. R. (2006) · Surgical Infections · doi:10.1089/sur.2006.7.s2-77 · Cited by 30
Deaney, N. B., & Tate, H. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.5.975 · Cited by 27
Angerås, M. H., Darle, N., Hamnström, K., Ekelund, M., Engström, L., Takala, J. A., Viste, A., & Holme, J. B. (1996) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549609037950 · Cited by 26
Grasela, T. H., Welage, L. S., Walawander, C. A., Timm, E. G., Pelter, M. A., Poirier, T. I., & Walters, J. K. (1990) · DICP · doi:10.1177/106002809002401215 · Cited by 23
Hibbard, M. L., Kopelman, T. R., O’Neill, P. J., Maly, T. J., Matthews, M. R., Cox, J. C., Vail, S. J., Quan, A. N., & Drachman, D. A. (2010) · Surgical Infections · doi:10.1089/sur.2009.046 · Cited by 13
Cited by
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Self-citationClinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027029 · Cited by 1,149
Metadata
- Authors
- Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2012-07
- Volume
- 25
- Issue
- 3
- Pages
- 450-470
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2145952139
- Cited by
- 836
- References
- 192
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.